gallein has been researched along with Disease Exacerbation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blaxall, BC; Kamal, FA; Lorenz, JN; Molkentin, JD; Nieman, ML; Sargent, MA; Travers, JG; Valiente-Alandi, I | 1 |
| Blaxall, BC; Hammes, SR; Kamal, FA; Mickelsen, DM; Moalem, J; Smrcka, AV; Travers, JG; Wegman, KM | 1 |
| Belmonte, SL; Blaxall, BC; Casey, LM; Dunaevsky, O; Lopes, CM; Matavel, A; Migdalovich, D; Nwakanma, FE; Pistner, AR; Smrcka, AV; Stolpnik, O; Vorobiof, G | 1 |
3 other study(ies) available for gallein and Disease Exacerbation
| Article | Year |
|---|---|
Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
Topics: Animals; Disease Models, Animal; Disease Progression; G-Protein-Coupled Receptor Kinase 2; Heart Failure; Mice; Mice, Knockout; Myocardial Ischemia; Myocardium; Myofibroblasts; Ventricular Remodeling; Xanthenes | 2017 |
Simultaneous adrenal and cardiac g-protein-coupled receptor-gβγ inhibition halts heart failure progression.
Topics: Adrenal Glands; Animals; Cells, Cultured; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; G-Protein-Coupled Receptor Kinase 2; Heart; Heart Failure; Humans; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocardium; Stroke Volume; Treatment Outcome; Xanthenes | 2014 |
Small molecule disruption of G beta gamma signaling inhibits the progression of heart failure.
Topics: Animals; Cyclohexanes; Disease Progression; Female; GTP-Binding Protein beta Subunits; GTP-Binding Protein gamma Subunits; Heart Failure; HL-60 Cells; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; Signal Transduction; Xanthenes; Xenopus | 2010 |